| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 22.39▲ | 22.43▲ | 23.07▼ | 21.88▲ | 40.88▼ |
| MA10 | 22.27▲ | 23.21▼ | 23.59▼ | 32.41▼ | 48.51▼ |
| MA20 | 22.44▲ | 23.64▼ | 23.09▼ | 42.50▼ | 61.12▼ |
| MA50 | 23.42▼ | 22.01▲ | 24.12▼ | 51.73▼ | 72.04▼ |
| MA100 | 23.29▼ | 26.81▼ | 38.88▼ | 62.94▼ | 55.98▼ |
| MA200 | 21.51▲ | 40.30▼ | 45.45▼ | 71.00▼ | 30.82▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.087▲ | -0.301▼ | 0.217▲ | -2.513▼ | -4.201▼ |
| RSI | 47.258▼ | 44.807▼ | 43.144▼ | 26.987▼ | 24.366▼ |
| STOCH | 86.548▲ | 18.863▼ | 47.958 | 10.092▼ | 15.736▼ |
| WILL %R | 0.000▲ | -69.259 | -69.259 | -87.076▼ | -92.500▼ |
| CCI | 123.499▲ | -89.705 | -123.942▼ | -64.145 | -179.564▼ |
|
Sunday, November 08, 2026 07:35 AM
Revolution Medicines has a big drug making headlines, and Royalty Pharma gets a bite of the action without doing anything at all.
|
|
Tuesday, October 27, 2026 05:56 AM
Aptar Pharma acquired Pulmotree to expand in pulmonary drug delivery. Here is what the update shows and what to watch next.
|
|
Monday, October 26, 2026 02:02 PM
A pharmaceutical giant valued at roughly $1.135 trillion, Eli Lilly (NYSE: LLY) heads into its October 29 third-quarter earnings report with an uncomfortably ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/11/26 | 24.49 | 24.535 | 21.77 | 22.62 | 130,376 |
| 09/11/26 | 23.00 | 24.44 | 22.6094 | 24.11 | 93,591 |
| 06/11/26 | 21.29 | 23.385 | 20.70 | 23.00 | 194,272 |
| 05/11/26 | 18.75 | 20.86 | 17.40 | 20.70 | 438,828 |
| 04/11/26 | 22.10 | 22.48 | 18.10 | 18.96 | 498,200 |
| 03/11/26 | 25.07 | 26.6876 | 21.09 | 21.55 | 985,127 |
| 02/11/26 | 29.20 | 29.9376 | 18.90 | 26.20 | 1,819,495 |
| 30/10/26 | 56.90 | 57.00 | 54.96 | 54.98 | 95,816 |
| 29/10/26 | 56.35 | 57.79 | 55.835 | 56.69 | 67,461 |
| 28/10/26 | 54.25 | 56.13 | 53.65 | 55.32 | 70,918 |
|
|
||||
|
|
||||
|
|